Bumetanide 0.25 MG/ML Injectable Solution

Known as: BUMETANIDE 0.25MG/ML INJ_#1, BUMETANIDE 0.25 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION [Bumetanide]_#2, BUMETANIDE 0.25 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION [Bumetanide] 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1993-2016
01219932016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Intranodal schawnomas are extremely rare. Just a few cases have been described before. Clinical presentation comprises not only… (More)
  • figure 1
  • figure 2
Is this relevant?
2016
2016
PURPOSE Ultrasound is a well-established imaging modality in the assessment of malignant cervical lymphadenopathy. With the use… (More)
  • figure 1
  • figure 4
  • figure 2
  • figure 3
  • figure 5
Is this relevant?
2007
2007
OBJECTIVE To evaluate whether a preliminary aspiration (ASP) of the cystic component and/or using spinal needles in complex… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2001
2001
A case of intranodal myofibroblastoma with amianthoid fibres was studied by histology, immunohistochemistry and electron… (More)
Is this relevant?
1999
1999
BACKGROUND AND PURPOSE Although the role of gray-scale sonography for neck nodes is well documented, it plays a limited role in… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Review
1999
Review
1999
Percutaneous ethanol injection (PEI) is proposed for treatment of autonomously functioning thyroid nodule, especially for small… (More)
Is this relevant?
1996
1996
RATIONALE AND OBJECTIVES Nodal response to chemotherapy in head and neck squamous cell carcinoma depends on the vascularization… (More)
Is this relevant?
1993
1993
PURPOSE analyze the utility of transcatheter ablation with high-frequency currents to create different experimental models of… (More)
Is this relevant?